PRNewsWire - Health

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy
MemorialCare's Two Long Beach Hospitals Receive ABRET LAB-EEG Accreditations for Outstanding Neurodiagnostic Testing
Lundbeck receives orphan drug designation in the US and EU for Lu AG13909 for the treatment of patients with congenital adrenal hyperplasia
Navamedic ASA - Investor presentation regarding the acquisition of the business of dne pharma AS